These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18688225)

  • 1. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 2. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA inspections in Canada.
    Oliver EA
    J Parenter Sci Technol; 1991; 45(3):142-6. PubMed ID: 1886042
    [No Abstract]   [Full Text] [Related]  

  • 4. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
    Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double standards in GMP deduplication row.
    Hodgson J; Fox JL
    Nat Biotechnol; 1996 Dec; 14(13):1647-8. PubMed ID: 9634839
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA in the global village.
    Williams RD
    FDA Consum; 1992; 26(6):14-7. PubMed ID: 10119705
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation--mission completed?
    Sharp J
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract]   [Full Text] [Related]  

  • 10. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Europe and FDA agree to limited inspections.
    Fox JL
    Nat Biotechnol; 1997 Aug; 15(8):714-5. PubMed ID: 9333519
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
    Awang DV
    Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036
    [No Abstract]   [Full Text] [Related]  

  • 13. The outer limits of FDA inspections.
    Scarlett T
    J Parenter Sci Technol; 1991; 45(4):204-8. PubMed ID: 1770416
    [No Abstract]   [Full Text] [Related]  

  • 14. LyphoMed, FDA reach agreement.
    Wagner M
    Mod Healthc; 1988 May; 18(22):6. PubMed ID: 10287683
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA implementation of standards developed by the International Conference on Harmonisation.
    Booth PM
    Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA initiative will enhance drug good manufacturing practices.
    FDA Consum; 2002; 36(6):4. PubMed ID: 12523283
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(225):65717-8. PubMed ID: 14631936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Conference on Harmonisation; final recommendations on the revision of the permitted daily exposures for two solvents, n-methylpyrrolidone and tetrahydrofuran, according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(219):64352-3. PubMed ID: 14619948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA and mutual recognition agreements: five models of harmonization.
    Merrill RA
    Food Drug Law J; 1998; 53(1):133-7. PubMed ID: 11795329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.